The
Renaissance
Series

TRANSFORMING VALUE

TRANSFORMING TRUST

Building patient trust and belief in the value of medicines

Join us in Paris on 10th June for our latest Thought Leadership Forum 

PARIS 2022

More Details

What is Renaissance

Goal & Purpose

Patient belief in medicine is challenged, access to healthcare professionals is becoming more remote and patients are faced with multiple sources of complex and sometimes unreliable information.

Building patient trust in pharma is now more important than ever and a change in how pharma recognises and communicates patient value is imperative.

What steps must we as an industry take to build patient trust and belief in the value of medicines?

PARIS FORUM

  • A unique opportunity to spend a day in closed meeting discussion of the most important challenge for pharma today

 

  • Hear the views of expert speakers from a physician, payer, patient and pharma perspective, all actively involved in addressing this challenge
  • Reflect on your own company strategy through informed discussion with the faculty and like-minded senior influencers from leading pharma companies

In this invitation only meeting, designed for Senior Pharmaceutical Executives across disciplines, Adelphi invites you to engage in thought-leading debate on the role of the pharmaceutical industry in embracing the change required to transform patient value and transform trust.

Expert Faculty

Stuart Cooper
CEO Adelphi, Meeting Chair

David Gillen
Chief Medical Officer, Norgine

John-Kenneth Sake
Medical Lead Neurology & Immunology Merck KGaA

Neil Bertelsen
Patient Advocate & Patient Engagement Specialist

John Irwin
Consultant in Market Access; Expert Orphan Medicines & ATMPs

Bernard Revaz
Technologist CEO, Ayaru

What is the Renaissance Series?

Expert exchange on disruptive drivers in healthcare

Adelphi’s Renaissance events have, over the years, become established as unique, one day invitation-only forums, at which senior Pharma leaders have the opportunity for discussion of the most dynamic drivers of major and disruptive change in Pharma in an intimate setting.

One Day Thought Leadership Forums based on issues that are driving major change in our industry, most recent forums have addressed:

  • Striving for Transformational Value 2018-2020
  • Patientcentricity: Defining our role 2016-2017
  • Real World Evidence: the new standard of proof? 2014-2015
  • Personalised Medicine: Moving from promise to practice 2012-2013

Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.

The
Renaissance
Series

TRANSFORMING VALUE
TRANSFORMING TRUST:

“What steps must we as an industry take to build patient trust and belief in the value of medicines?”

Building patient trust and belief in the value of medicines

NEXT FORUM: PARIS, 10th JUNE 2022

Goal & Purpose to PARIS 2022

More Details

What is the Renaissance Series?

Goal & Purpose

Patient belief in medicine is challenged, access to healthcare professionals is becoming more remote and patients are faced with multiple sources of complex and sometimes unreliable information.

Building patient trust in pharma is now more important than ever and a change in how pharma recognises and communicates patient value is imperative.

“What steps must we as an industry take to achieve the desired transformation in healthcare?”

Why Attend?

  • A unique opportunity to spend a day in closed meeting discussion of the most important challenge for pharma today

 

  • Hear the views of expert speakers from a physician, payer, patient and pharma perspective, all actively involved in addressing this challenge
  • Reflect on your own company strategy through informed discussion with the faculty and like-minded senior influencers from leading pharma companies

In this invitation only meeting, designed for Senior Pharmaceutical Executives across disciplines, Adelphi invites you to engage in thought-leading debate on the role of the pharmaceutical industry in embracing the change required in the quest for Transformational Value.

Expert Faculty

Stuart Cooper
CEO Adelphi, Meeting Chair

David Gillen
Chief Medical Officer, Norgine

John-Kenneth Sake
Medical Lead Neurology & Immunology Merck KgA

Patrick Papazian
Patient Advocacy & Innovation Director, Galapogos and practising physician

Neil Bertelsen

John Irwin
Consultant in Market Access; Expert Orphan Medicines & ATMPs

Bernard Ravaz
Technologist CEO, Ayaru

What is the Renaissance Series?

Expert exchange on disruptive drivers in healthcare

Adelphi’s Renaissance events have, over the years, become established as unique, one day invitation-only forums, at which senior Pharma leaders have the opportunity for discussion of the most dynamic drivers of major and disruptive change in Pharma in an intimate setting.

One Day Thought Leadership Forums based on issues that are driving major change in our industry, most recent forums have addressed:

  • Striving for Transformational Value 2018-2020
  • Patientcentricity: Defining our role 2016-2017
  • Real World Evidence: the new standard of proof? 2014-2015
  • Personalised Medicine: Moving from promise to practice 2012-2013

Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.